Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disease that is characterized by the production of autoantibodies to a spectrum of nuclear antigens, and the development of inflammatory Processes potentially affecting multiple organ systems with varied clinical manifestations. Although the etiology of SLE is still unclear, it has been established that genetic factors play an important role in determining disease susceptibility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kotzin, BL: Systemic lupus erythematosus. Cell 85:303–306, 1996
Wakeland, EK, Wandstrat, AE, Liu, K, and Morel, L: Genetic dissection of systemic lupus erythematosus. Curr. Opin. Immunol. 11:701–707, 1999
Vyse TJ, Kotzin BL: Genetic susceptibility to systemic lupus erythematosus. Ann. Rev. Immunol. 16:261–292,1998
Foster MH: Relevance of systemic lupus erythematosus nephritis animal models to human disease. Semin. Nephrol. 19:12–24,1999
Morel L, Rudofsky UH, Longmate JA, Schiffenbauer J, Wakeland EK: Polygenic control of susceptibility to murine systemic lupus erythematosus. Immunity 1:219–229, 1994
Drake CG, Babcock SK, Palmer E, Kotzin BL: Genetic analysis of the NZB contribution to lupus-like autoimmune disease in (NZB x NZW)F1 mice. Proc. Natl. Acad. Sci. U.S.A. 91:4062–4066, 1994
Kono DH, Burlingame RW, Owens DG, Kuramochi A, Balderas RS, Balomenos D, Theofilopoulos AN: Lupus susceptibility loci in New Zealand mice. Proc. Natl. Acad. Sci. U. S. A. 91:10168–10172,1994
Hogarth MB, Slingsby JH, Allen PJ, Thompson EM, Chandler P, Davies KA, Simpson E, Morley BJ, Walport MJ: Multiple lupus susceptibility loci map to chromosome 1 in BXSB mice. J. Immunol. 161:2753–2761, 1998
Watson ML, Rao JK, Gilkeson GS, Ruiz P, Eicher EM, Pisetsky DS, Matsuzawa A, Rochelle JM, Seldin MF: Genetic analysis of MRL-Ipr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. J. Exp. Med. 176:1645–1656, 1992
Vidal S, Kono DH, Theofilopoulos AN: Loci predisposing to autoimmunity in MRLFasIF and C57BL/6-FasiP` mice. J. Clin. Invest.101:696–702, 1998
Morel L, Mohan C, Yu Y, Schiffenbauer J, Rudofsky UH, Tian N, Longmate JA, Wakeland EK: Multiplex inheritance of component phenotypes in a murine model of lupus. Mamm, Genome, 10:176–181, 1999
Morel L, Yu Y, Blenman KR, Caldwell RA, Wakeland EK: Production of congenie mouse strains carrying genomic intervals containing SLE-susceptibility genes derived from the SLE-prone NZM2410 strain. Mamm. Genome 7:335–339, 1996
Mohan C, Morel L, Yang P, Watanabe H, Croker B, Gilkeson G, Wakeland EK: Genetic dissection of lupus pathogenesis: a recipe for nephrophilic autoantibodies. J. Clin. Invest. 103:1685–1695, 1999
Morel L, Croker BP, Blenman KR, Mohan C, Huang G, Gilkeson G, Wakeland EK: Genetic reconstitution of systemic lupus erythematosus immunopathology with poly-congenie murine strains. Proc. Natl. Acad. Sci. U.S.A. 97:6670–6675, 2000
Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ: Homozygous C 1 q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 19:56–59, 1998
Bickerstaff MC, Botto M, Hutchinson WL, Herbert J, Tennent GA, Bybee A, Mitchell DA, Cook HT, Butler PJ, Walport MJ, Pepys MB: Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 5:694–697, 1999
Balomenos D, Martin-Caballero J, Garcia MI, Prieto I, Flores JM, Serrano M, Martinez AC: The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med. 6:171–176, 2000
Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata, S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314–317, 1992
Roths JB, Murphy ED, Eicher EM: A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J. Exp. Med. 159:1–20,1984
Cornall RJ, Cyster JG, Hibbs ML, Dunn AR, Otibopy KL, Clark EA, Goodnow CC: Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection. Immunity 8:497–508, 1998
Clynes R, Dumitru C, Ravetch JV: Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279:1052–1054, 1998
Mohan C, Yu Y, Morel L, Yang P, Wakeland EK: Genetic dissection of SLE pathogenesis:S1e3on murine chromosome 7 impacts T cell activation, differentiation, and cell death. J. Immunol. 162:6492–6502, 1999
Lajaunias F, Ibnou-Zekri N, Fossati-Jimack L, Chicheportiche Y, Parkhouse RM, Mary C, Reininger L, Brighouse G, Izui S: Polymorphisms in the Cd22 gene of inbred mouse strains. Immunogenetics 49:991–995, 1999
Gorelik L, Flavel RA: Abrogation of TGF signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12:171–181, 2000
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Liu, K., Wakeland, E.K. (2001). Delineation of the Pathogenesis of Systemic Lupus Erythematosus by Using Murine Models. In: Gupta, S. (eds) Mechanisms of Lymphocyte Activation and Immune Regulation VIII. Advances in Experimental Medicine and Biology, vol 490. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1243-1_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1243-1_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5458-1
Online ISBN: 978-1-4615-1243-1
eBook Packages: Springer Book Archive